Category: Emergent

Emergent Receives FDA Warning Letter Over Quality Control Issues

Emergent BioSolutions Inc. said on Friday it had received a warning letter from the Food and Drug Administration (FDA), citing certain deficiencies at the contract drugmaker’s manufacturing facility in Baltimore, Maryland. The FDA pointed to deficiencies in cleaning and maintenance of equipment to prevent contamination of drug product and also recommended the company review its…


US Cancels Contract With Major COVID-19 Vaccine Manufacturer

The United States government has canceled a contract with Emergent BioSolutions, a major vaccine manufacturer that came under investigation after it was blamed for a bad batch of 15 million doses of Johnson & Johnson’s COVID-19 vaccine. The Department of Health and Human Services and Emergent mutually agreed to end the contract on Nov. 1,…